Published in Medical Letter on the CDC and FDA, December 10th, 2006
Doxycycline tablets are a generic version of Doak Dermatologics' Adoxa tablets, which are manufactured by Par Pharmaceuticals. Doxycycline tablets had U.S. sales of approximately $56 million for the three strengths approved for the 12-month period ended June 30, 2006, according to IMS Health.
Mylan Laboratories Inc. is a pharmaceutical company with three principal subsidiaries: Mylan Pharmaceuticals Inc.,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.